Development of an expert professional curriculum for antimicrobial pharmacists in the UK
Antibiotics
Natural antimicrobial peptides against Mycobacterium tuberculosis
The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection
Genome-wide analysis reveals two novel mosaic regions containing an ACME with an identical DNA sequence in the MRSA ST398-t011 and MSSA ST8-t008 isolates
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
Novel gentamicin resistance genes in Campylobacter isolated from humans and retail meats in the USA
Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa
New plasmid-mediated aminoglycoside 6′-N-acetyltransferase, AAC(6′)-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolate
Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria
Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani
A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping
A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients
Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans
Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species
Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam
OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity
Colistin and doripenem combinations against Pseudomonas aeruginosa
Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections
Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15
Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaques
Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adults
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients
Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir
Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients
Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany
Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000–12
Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia
Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women
Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA
An evaluation of the association between an antimicrobial stewardship score and antimicrobial usage
Characterization of KPC-type carbapenemase-producing Klebsiella pneumoniae strains isolated in the Arabian Peninsula
NOTA
Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients
Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells